Molecular mechanisms underlying the tetrandrine-mediated reversal of the fluconazole resistance of Candida albicans. (June 2013)
- Record Type:
- Journal Article
- Title:
- Molecular mechanisms underlying the tetrandrine-mediated reversal of the fluconazole resistance of Candida albicans. (June 2013)
- Main Title:
- Molecular mechanisms underlying the tetrandrine-mediated reversal of the fluconazole resistance of Candida albicans
- Authors:
- Zhang, Xiaoli
Guo, Hui
Gao, Laiqiang
Song, Yanjun
Li, Shuixiu
Zhang, Hong - Abstract:
- <abstract> <title>Abstract</title> <p> <italic>Context</italic>: Our previous study demonstrated that tetrandrine (TET) could reverse the resistance of <italic>Candida albicans</italic> to fluconazole.</p> <p> <italic>Objective</italic>: The aim of this study was to investigate the molecular mechanism underlying this action.</p> <p> <italic>Materials and methods</italic>: Real-time reverse transcription polymerase chain reaction (real-time RT-PCR) was performed to compare the expression levels of the drug resistance genes <italic>CDR1, CDR2, MDR1, FLU1</italic> and <italic>ERG11</italic> in fluconazole-sensitive CA-3 and resistant CA-16 cells that were either treated with FLC and/or TET or left as untreated controls. In addition, intracellular ATP levels were measured using an ATP assay kit, and the expression level of the energy metabolism gene <italic>ADH1</italic> was measured by real-time RT-PCR.</p> <p> <italic>Results</italic>: Compared with FLC/TET-free conditions, FLC + TET treatment strains showed statistically different (<italic>p</italic> &lt; 0.05) expression of <italic>CDR1</italic> and <italic>CDR2</italic> (increased in the FLC-sensitive strains, while decreased in the FLC-resistant strains), <italic>MDR1</italic> (increased in the FLC-resistant strains), <italic>FLU1</italic> and <italic>ERG11</italic> (increased in the FLC-sensitive strains), <italic>ADH1</italic> (decreased in both the FLC-sensitive and the FLC-resistant strains). And also, the FLC + TET<abstract> <title>Abstract</title> <p> <italic>Context</italic>: Our previous study demonstrated that tetrandrine (TET) could reverse the resistance of <italic>Candida albicans</italic> to fluconazole.</p> <p> <italic>Objective</italic>: The aim of this study was to investigate the molecular mechanism underlying this action.</p> <p> <italic>Materials and methods</italic>: Real-time reverse transcription polymerase chain reaction (real-time RT-PCR) was performed to compare the expression levels of the drug resistance genes <italic>CDR1, CDR2, MDR1, FLU1</italic> and <italic>ERG11</italic> in fluconazole-sensitive CA-3 and resistant CA-16 cells that were either treated with FLC and/or TET or left as untreated controls. In addition, intracellular ATP levels were measured using an ATP assay kit, and the expression level of the energy metabolism gene <italic>ADH1</italic> was measured by real-time RT-PCR.</p> <p> <italic>Results</italic>: Compared with FLC/TET-free conditions, FLC + TET treatment strains showed statistically different (<italic>p</italic> &lt; 0.05) expression of <italic>CDR1</italic> and <italic>CDR2</italic> (increased in the FLC-sensitive strains, while decreased in the FLC-resistant strains), <italic>MDR1</italic> (increased in the FLC-resistant strains), <italic>FLU1</italic> and <italic>ERG11</italic> (increased in the FLC-sensitive strains), <italic>ADH1</italic> (decreased in both the FLC-sensitive and the FLC-resistant strains). And also, the FLC + TET treatment decreased the intracellular ATP levels in both the FLC-sensitive and the FLC-resistant strains (<italic>p</italic> &lt; 0.05).</p> <p> <italic>Discussion and conclusion</italic>: These results suggest that changes in the expression levels of the drug resistance genes <italic>CDR1</italic> and <italic>CDR2</italic>, the cellular ATP supply and the expression level of the energy metabolism gene <italic>ADH1</italic> contribute to the TET-mediated reversal of the fluconazole resistance of <italic>C. albicans</italic>.</p> </abstract> … (more)
- Is Part Of:
- Pharmaceutical biology. Volume 51:Number 6(2013:Jun.)
- Journal:
- Pharmaceutical biology
- Issue:
- Volume 51:Number 6(2013:Jun.)
- Issue Display:
- Volume 51, Issue 6 (2013)
- Year:
- 2013
- Volume:
- 51
- Issue:
- 6
- Issue Sort Value:
- 2013-0051-0006-0000
- Page Start:
- 749
- Page End:
- 752
- Publication Date:
- 2013-06
- Subjects:
- Pharmacognosy -- Periodicals
Materia medica, Vegetable -- Periodicals
615.321 - Journal URLs:
- http://www.tandfonline.com/toc/iphb20/current ↗
http://informahealthcare.com/journal/phb ↗
http://informahealthcare.com ↗ - DOI:
- 10.3109/13880209.2013.764537 ↗
- Languages:
- English
- ISSNs:
- 1388-0209
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6442.767000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3490.xml